BRIEF-Ackman to call Valeant board Thursday to discuss drug pricing

Wed Apr 27, 2016 6:31pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 27 (Reuters) - Valeant Pharmaceuticals International Inc

* Board member Bill Ackman says hopes to call board Thursday to discuss reducing prices of four drugs discussed at Senate hearing

* Valeant board member Ackman says "my recommendation will be to reduce the prices"

* Ackman says decision to reduce Valeant drug prices is a board call

* Ackman says regrets didn't do more due diligence on pricing at Valeant

* Ackman tells Senate committee "a lot is going to change" at Valeant; pricing will be top of mind

* Ackman says first priority to make sure company doesn't go bankrupt Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)